Summary & Overview
Other Endocrine, Nutritional and Metabolic O.R. Procedures with CC: Inpatient Reimbursement Overview
DRG 629 includes other endocrine, nutritional, and metabolic operating room procedures accompanied by a Complication or Comorbidity and defines the clinical resource category for payment. It matters for inpatient reimbursement because correct grouping influences hospital prospective payment rates and case mix indexing under the Medicare program.
DRG 629 Overview
DRG 629 covers inpatient cases involving other endocrine, nutritional, and metabolic operations performed in the operating room with an accompanying Complication or Comorbidity. Typical procedures include surgical interventions for metabolic disorders, endocrine gland procedures other than major thyroid or adrenal resections, and operations addressing nutritional- or metabolic-related complications. This Diagnosis-Related Group matters for Medicare payment because it groups similar clinical resource use to determine prospective payment for hospitals under the inpatient program. Accurate assignment affects reimbursement through case mix and payment relativity within the Medicare Severity Diagnosis-Related Group system.
Clinical Trials
- Perioperative metabolic optimization trials: randomized or pragmatic studies testing protocols to manage acute endocrine and metabolic derangements (eg, severe electrolyte disturbances, adrenal insufficiency, or complex glycemic control) in patients undergoing operative procedures categorized under this DRG. These studies enroll hospitalized adults who require an operative endocrine, nutritional or metabolic procedure and have complicating comorbidities or complications (the CC component), with outcomes including time to metabolic stabilization, perioperative morbidity, length of stay, and insulin or steroid utilization. Results inform clinicians on best practices for acute perioperative management and help payers evaluate the impact of protocolized care on resource use and avoidable complications.
- Comparative effectiveness research on procedural approaches and perioperative management strategies: observational cohort studies or pragmatic trials comparing different surgical or interventional techniques and adjunctive perioperative care (such as minimally invasive versus open approaches for endocrine-related procedures, or varying nutrition support strategies) in patients with metabolic or nutritional disorders and documented complications. These studies focus on heterogeneous inpatient populations within the DRG who present with CC-level severity, assessing outcomes like complication rates, readmissions, functional recovery, and total costs of care. Findings guide hospitals and payers in selecting clinically effective, cost-efficient procedural and perioperative care pathways for this high-acuity group.
- Post-discharge outcomes and transitional care studies: prospective longitudinal studies evaluating discharge planning, post-acute nutrition or endocrine management, and readmission prevention among patients who had an endocrine/nutritional/metabolic operative procedure with complications. Typical cohorts include medically complex inpatients with ongoing metabolic therapies (eg, parenteral nutrition, corticosteroid management, or intensive glycemic regimens) at discharge; endpoints include 30- and 90-day readmissions, outpatient resource utilization, patient-reported outcomes, and medication or nutrition-related adverse events. This research is critical for payers and providers to identify interventions that reduce costly readmissions and improve continuity of care for vulnerable patients in this DRG.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.